Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Profit Margin (Quarterly): 27.11% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 27.11% |
| June 30, 2023 | -5.11% |
| March 31, 2023 | -82.24% |
| December 31, 2022 | -143.3% |
| September 30, 2022 | -505.7% |
| June 30, 2022 | -437.9% |
| March 31, 2022 | -63.41% |
| December 31, 2021 | -132.8% |
| September 30, 2021 | -405.4% |
| June 30, 2021 | -181.4% |
| March 31, 2021 | -216.8% |
| December 31, 2020 | 36.58% |
| September 30, 2020 | -123.0% |
| June 30, 2020 | -161.7% |
| March 31, 2020 | -218.9% |
| December 31, 2019 | 10.73% |
| September 30, 2019 | -163.8% |
| June 30, 2019 | -279.5% |
| March 31, 2019 | -509.7% |
| December 31, 2018 | -311.6% |
| September 30, 2018 | -428.3% |
| June 30, 2018 | -448.2% |
| March 31, 2018 | -194.9% |
| December 31, 2017 | -33.25% |
| September 30, 2017 | -668.4% |
| Date | Value |
|---|---|
| June 30, 2017 | -22.72% |
| March 31, 2017 | -60.86% |
| September 30, 2016 | -584.0% |
| June 30, 2016 | -619.9% |
| March 31, 2016 | -162.0% |
| December 31, 2015 | -184.3% |
| September 30, 2015 | -227.2% |
| June 30, 2015 | -241.6% |
| March 31, 2015 | -189.2% |
| December 31, 2014 | 28.23% |
| September 30, 2014 | -168.8% |
| June 30, 2014 | -461.4% |
| March 31, 2014 | -544.8% |
| December 31, 2013 | 12.68% |
| September 30, 2013 | -65.20% |
| June 30, 2013 | -571.0% |
| March 31, 2013 | -5.40% |
| December 31, 2012 | -933.9% |
| September 30, 2012 | -615.8% |
| June 30, 2012 | -759.3% |
| March 31, 2012 | -574.1% |
| December 31, 2011 | -167.4% |
| September 30, 2011 | -768.3% |
| June 30, 2011 | -248.3% |
| March 31, 2011 | -287.9% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-505.7%
Minimum
Sep 2022
36.58%
Maximum
Dec 2020
-169.3%
Average
-152.5%
Median
Profit Margin (Quarterly) Benchmarks
| AbbVie Inc | 11.12% |
| Pfizer Inc | -23.64% |
| Johnson & Johnson | 15.22% |
| Merck & Co Inc | 30.19% |
| Cerevel Therapeutics Holdings Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -24.37% |
| Return on Assets | -14.52% |
| Return on Invested Capital | -22.25% |
| Gross Profit Margin (Quarterly) | 98.10% |
| Operating Margin (Quarterly) | 22.88% |
| Return on Net Operating Assets | -105.4% |